Use of proteasome inhibitors to treat dry eye disorders
US6740674B2 · kind B2 · utility
28Cited by
29References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2002 |
| Grant date | May 25, 2004 |
| Priority date | — |
| Expiry date | Jul 25, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Proteasome inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.